Navigation Links
Moffitt Cancer Center researcher & colleagues test new drug for patients with neuroendocrine tumors
Date:8/6/2012

A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG. The Phase II, open-label, multicenter study in patients with advanced neuroendocrine tumors (NET) whose symptoms were no longer responsive to octreotide LAR therapy found that the drug was effective and well tolerated in controlling patient symptoms.

The study results are reported in a recent issue of Endocrine-Related Cancer, a publication of the Society for Endocrinology.

"Neuroendocrine tumors are often asymptomatic and, by the time of diagnosis, have frequently metastasized, usually to the liver," said the study's corresponding author, Larry K. Kvols, M.D., a senior member at Moffitt and section head of neuroendocrine oncology. "Surgery is essential in managing metastatic NET and can be curative for early disease, but the majority of patients need further treatment."

According to Kvols, octreotide and lanreotide, drugs that mimic natural somatostatin, have been "the mainstay" for symptom management of neuroendocrine tumors. However, many patients eventually fail to respond to this treatment and have poor prognoses.

"Pasireotide is a novel multireceptor-targeted somatostatin analogue that binds to four of the five known somatostatin receptor subtypes," said Kvols, whose research is in experimental therapies for neuroendocrine cancer. "Because of its binding ability, it may offer symptom reduction for patients who have eventually failed to respond to traditional therapy."

The multicenter clinical trial, conducted at sites in the United States and Europe, enrolled 89 patients and evaluated 44 for efficacy and 45 for tolerability. Pasireotide "effectively controlled symptoms." Evaluation of tumor response in 23 patients showed 13 with stable disease and 10 with progressive disease. The
'/>"/>

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Moffitt researchers find cancer therapies affect cognitive functioning among breast cancer survivors
2. Moffitt Cancer Center researchers: Quality of life as important as quantity of life
3. Moffitt Cancer Center researchers working at frontiers of melanoma research
4. Moffitt researchers find adolescents with cancer concerned about their future reproductive health
5. Moffitt researcher publishes book on nutritional management of cancer treatment effects
6. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
7. Researchers creating designer lymph nodes based on Moffitts Total Cancer Care initiative
8. Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival
9. Moffitt Cancer Center researchers develop and test new anti-cancer vaccine
10. Moffitt researcher, colleagues find success with new immune approach to fighting some cancers
11. Moffitt researchers: Darwins principles say cancer will always evolve to resist treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... Doctor Mike Hamilton from Inception Chiropractic ... company website. The Inception website is a place for ... It's also a place for potential clients to learn ... When contacted at his office, Doctor Hamilton said, "We're ... website. Our site is obviously a great place for ...
(Date:7/14/2014)... 2014 Love Digits LLC has successfully ... Digits. The App brings ancient astrology to the modern ... their compatibility using a five-star rating system. By entering ... instantaneously test their compatibility for love and marriage across ... app’s five-star rating system generates a weighted average of ...
(Date:7/14/2014)... Spine Team Texas continues to stay ... treatment and recovery. Currently all physical therapists at Spine ... for certification in The McKenzie Method. Two therapists, Craig ... program. , “We require certification of our therapists because ... outcomes for spine pain patients,” said Mark Hood, CEO ...
(Date:7/14/2014)... Townsend Security, a leading authority ... IBM i (AS/400, iSeries) Two Factor Authentication Partner ... threats evolve and make passwords ineffective for system ... their applications and implement two factor authentication (2FA). ... for ISVs on the IBM i platform to ...
(Date:7/14/2014)... Crystal Dental has recently announced that it will ... made via LAD Solutions in in order to increase awareness ... in order to draw in new patients that can now ... Dental offers a variety of services for both routine and ... include cosmetic dentistry procedures such as porcelain veneers and dental ...
Breaking Medicine News(10 mins):Health News:Doctor Mike Hamilton From Inception Chiropractic Websites Announces the Launch of Their New Website 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 3Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 3Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 3Health News:Crystal Dental Announces the Opening of New Office Location in Sacramento 2
... Centre and Kenya has been asked to spell out, account ... intended 134 million. The fund was provided to Kenya to ... have to provide the accounts of how the money was ... Kenya has been ridden with serious corruption problems that have ...
... The burden of HIV, malaria and Tuberculosis in most ... //The European Union, UNAIDS, WHO and the Indian Government ... the diseases. ,"These diseases mostly affect the ... aim to share our experiences and develop strategies to ...
... drug manufactured by German pharmaceutical company TeGenero by medical research ... designed to treat rheumatoid arthritis, leukaemia and multiple sclerosis was ... who fell seriously ill after taking part in a drug ... brain was on fire. Student Nav Modi, 24, said that ...
... an NGO official India’s population stabilization solely rests on ... which has the highest fertility rates. ,'India's population ... an immediate lead in checking population growth' A.R. Nanda, ... ,'If high growth states like Bihar and Uttar Pradesh, ...
... funds to the tune of ?4m or more will be ... This spending should take care of containing// the unhealthy trend, ... gone up by almost 50%. ,A senior medical ... problems with suicidal tendencies, according to Mr Woodward. To enable ...
... high risk of the potentially-fatal condition of pre-eclampsia, should ... Vitamin C and E. // Recent research has suggested that ... and can trigger pre-eclampsia. ,Pre-eclampsia, is a dangerous condition ... women which is a common cause of deaths and still ...
Cached Medicine News:
(Date:7/11/2014)... , July 11, 2014 The consumer ... evolving across industry sectors to better identify winning ... ways to engage with and understand consumers, as ... and make critical purchasing decisions. ... Practices, LLC, one area where organizations can observe ...
(Date:7/11/2014)... July 11, 2014  Kindred Hospital Houston Northwest, ... the opening of its new outpatient wound healing ... to people with chronic, hard to heal wounds. ... lead to amputation, lower leg wounds related to ... closure, and traumatic injury wounds which are complex ...
(Date:7/11/2014)... , July 11, 2014  Veran ... company, announced today the positive, cost-effective final ... innovative SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous ... a percutaneous approach to biopsy when a ... patients and physicians experience positive financial outcomes ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Veran Medical Publishes Lung Cancer Patient Management Study 2
... (Nasdaq: NVAX ) announced today that it has ... H1N1 influenza vaccine in Mexico in collaboration with Avimex ... and pharmaceutical products for use in Mexico and more ... is providing financial support for the trial and is ...
... SHENYANG, China, Oct. 20 /PRNewswire-Asia-FirstCall/ -- 3SBio ... China-based biotechnology,company focused on researching, developing, manufacturing and marketing,biopharmaceutical ... of shareholders held on October 12, 2009. , ... re-elected Dr. Jing Lou and Mr.,Moujia Qi to serve ...
Cached Medicine Technology:Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 3Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 4Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: